Abstract
During a 3-year period, a clinical diagnosis of invasive candidosis was made in 8 out of 2054 consecutive surgical intensive care unit (ICU) patients. These patients were retrospectively matched with 16 control patients who underwent similar surgical procedures and had a similar clinical course except for negative Candida cultures. In all patients, Candida antigen (Ramco CandTec serum antigen test) and antibody serology (Candida HA test) were determined at least once a week during their stay. The antigen test was positive in 1/8 patients and 4/16 controls and thus did not differentiate patients with candidosis from non-infected controls. The HA antibody titer results fulfilled the manufacturer's criteria for positivity in 7/8 patients with candidosis and 2/16 control patients. Thus, the Candida HA antibody test, but not the Ramco antigen test, can be recommended to confirm a clinical diagnosis of invasive candidosis.
Author information
Authors and Affiliations
Additional information
Final revision received: 11 January 2001
Electronic Publication
Rights and permissions
About this article
Cite this article
Lepper, P.M., Wiedeck, H., Geldner, G. et al. Value of Candida antigen and antibody assays for the diagnosis of invasive candidosis in surgical intensive care patients. Intensive Care Med 27, 916–920 (2001). https://doi.org/10.1007/s001340100891
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001340100891